Betaxolol Tablets Rx
Generic Name and Formulations:
Betaxolol HCl 10mg+, 20mg; tabs; +scored.
Various generic manufacturers
Indications for Betaxolol Tablets:
Initially 10mg daily alone or added to diuretic therapy; may increase to 20mg daily after 7–14 days; usual max 20mg daily. Elderly or severe renal dysfunction: initially 5mg daily.
Sinus bradycardia. 2nd- or 3rd-degree AV block. Cardiogenic shock. Overt heart failure.
CHF. Bronchospastic disease, COPD. Diabetes. Hyperthyroidism. Renal or hepatic dysfunction. Avoid abrupt cessation. Surgery. SLE. Elderly. Pregnancy (Cat.C). Nursing mothers.
Increased cardiac effects of calcium channel blockers, digitalis. Bradycardia with catecholamine-depleting drugs. May block epinephrine. May interfere with glaucoma screening tests.
Bradycardia, headache, GI upset, dizziness, arthralgia, fatigue, dyspnea, chest pain, pharyngitis, impotence, heart failure, bronchospasm.
Formerly known under the brand name Kerlone.
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Treatment With Alemtuzumab May Frequently Induce Thyroid Dysfunction
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- NT-proBNP May Predict Cardiovascular Outcomes in Type 2 Diabetes
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation
- Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms
- Conservative Monitoring Strategy for Non-Functioning Pituitary Adenomas Evaluated
- FDA: Some Rx Drugs May Become Available Without Seeing a Doctor
- PM2.5 Contributes to Burden of Diabetes Mellitus Globally